Tuesday - February 24, 2026
Bayer Alleges J&J's Claims Regarding NUBEQA are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J's ERLEADA
February 24, 2026
WHIPPANY, New Jersey, Feb. 24 -- Bayer USA, an enterprise with core competencies in the life science fields of health care and nutrition, issued the following news on Feb. 23, 2026:

* * *

Bayer Alleges J&J's Claims Regarding NUBEQA(R) are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J's ERLEADA

Bayer files false advertising suit against J&J and Janssen Biotech

* Lawsuit seeks preliminary and permanent injun . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products